DCI Indonesia Tbk vs Phapros Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Phapros Tbk. trades at Rp256 (market cap 211.68B, 116.4K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 2237.9× Phapros Tbk.'s market cap, and Phapros Tbk. is more actively traded (116.4K versus 1K). Which is the better fit depends on your goals.
| DCII | PEHA | |
|---|---|---|
Market Cap | 473.71T | 211.68B |
Volume | 1K | 116.4K |
Lot | 10 | 1.16K |
Turnover | 194.12M | 29.27M |
Average Price | 194,120 | 251.47 |
Value | 194.12M | 29.27M |
Indicative Equilibrium Price | 199,000 | 256 |
Indicative Equilibrium Volume | 1 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →